ZNF503

Chr 10

zinc finger protein 503

Also known as: NOLZ-1, NOLZ1, Nlz2, ZEPPO2, ZPO2

Predicted to enable zinc ion binding activity. Involved in G1 to G0 transition involved in cell differentiation; negative regulation of cell population proliferation; and negative regulation of gene expression. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]

OMIMResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
Pubs (1 yr)
P/LP submissions
P/LP missense
0.35
LOEUF· LoF intol.
LOF
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.35LOEUF
pLI 0.946
Z-score 3.17
OE 0.07 (0.030.35)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
0.68Z-score
OE missense 0.90 (0.830.99)
349 obs / 386.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.07 (0.030.35)
00.351.4
Missense OE?0.90 (0.830.99)
00.61.4
Synonymous OE?1.28
01.21.6
LoF obs/exp: 1 / 13.6Missense obs/exp: 349 / 386.7Syn Z: -3.11

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

ZNF503 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →